Dublin, July 05, 2021 (GLOBE NEWSWIRE) -- The "Global Continuous Renal Replacement Therapy (CRRT) Market by Product (Disposables (Hemofilters, Bloodlines), Machine, Dialysates, Renal Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF), Patient (Adult, Pediatrics, Neonates), and Region - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
The global continuous renal replacement therapy market size is projected to reach USD 1.7 billion by 2026 from USD 1.2 billion in 2021, at a CAGR of 7.3% during the forecast period.
The dialysate and replacement fluid segment to capture the largest share in continuous renal replacement therapy market, by product, during the forecast period
The dialysate and replacement fluid segment is expected to witness the highest growth rate during the forecast period. The high growth in this owes to the significant rise in demand for CRRT in the treatment of hemodynamically unstable patients, the increased number of manufacturers offering dialysate and replacement fluids for renal replacement therapy, and the strong presence of players in the market.
The CVVHDF segment to witness highest growth rate in continuous renal replacement therapy market, by modality in 2021
The CVVHDF modality segment is anticipated to witness the highest growth rate during the forecast period. The growing preference of CVVHDF modality among a nephrologist and critical care physician, and the advantages such as better clearance of medium-sized solutes as compared to hemodialysis (owing to the combination of hemofiltration with the continuous HD procedure), proper acid-base balance without additional intervention, and a significant reduction in CRRT-related phosphate depletion area likely to play strong role in supporting the growth of the segment in the coming years.
The Adults segment accounted for the largest share of the continuous renal replacement therapy, by age group, in 2021
The rapidly growing cases of adult acute renal disease injury across the globe and the rising number of hospital admission among youth adults are playing a critical role in increasing the adoption of CRRT among adult age group population. Moreover, increasing frequency of aggressive surgical and medical interventions among adults, and the increasing the risk of developing AKI and further contributing to the market growth.
The Asia-Pacific market to grow at the highest CAGR during the forecast period
The continuous renal replacement therapy market is segmented into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Increase in the awareness of continuous renal replacement therapy, increasing healthcare expenditures, increasing patient population, rising sepsis incidence, increasing prevalence of hypertension & diabetes (major causes of AKI), the high use of CRRT in Australia and Japan, improving healthcare expenditure on renal diseases, and increasing accessibility to CRRT for AKI treatment.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Continuous Renal Replacement Therapy Market Overview
4.2 Continuous Renal Replacement Therapy Market Share, by Age Group, 2021
4.3 Asia-Pacific: Continuous Renal Replacement Therapy Market, by Product and Country
5 Market Overview
5.2 Market Dynamics
184.108.40.206 Increasing Incidence of Acute Kidney Injury (AKI)
220.127.116.11 Growing Number of ICU Patients with AKI and Increasing Incidence of Sepsis
18.104.22.168 Increasing Clinical Advantage of CRRT Over Intermittent Blood Purification
22.214.171.124 Technological Advancements and New Product Launches
126.96.36.199 Growing Prevalence of Diabetes and Hypertension
188.8.131.52 Stringent Regulatory Guidelines in North America
184.108.40.206 High Procedural Cost of CRRT
220.127.116.11 Emerging Markets in APAC and Row
18.104.22.168 Increasing Applications of CRRT
22.214.171.124.1 Evolution of CRRT from a Simple Renal Replacement Treatment to Multi-Organ Support Therapy
126.96.36.199.2 Progression of CRRT from Adaptive Renal Devices to Multipurpose Treatment Machines
188.8.131.52 Ongoing Research to Establish the Safety and Efficacy Profile of CRRT
184.108.40.206 Development of CRRT Systems for Pediatric Patients
220.127.116.11.1 The Carpediem Project
18.104.22.168 Untapped Growth Opportunities in North America
22.214.171.124 High Complexity of CRRT
126.96.36.199 Lack of Standard Treatment Guidelines in Developing Nations
188.8.131.52 Shortage of Trained ICU Professionals in Developing Nations
184.108.40.206 Poor Reimbursement Scenario in Developing Countries
220.127.116.11 Lack of Awareness About the Benefits of CRRT
5.3 Global Regulatory Landscape
5.4 Global Reimbursement Scenario
5.5 COVID-19 Impact on the CRRT Market
5.6 Value Chain Analysis
5.7 Ecosystem Coverage
5.8 Pricing Trend Analysis
5.9 Porter's Five Forces Analysis
6 Global Continuous Renal Replacement Therapy Market, by Product
7 Global Continuous Renal Replacement Therapy Market, by Modality
8 Global Continuous Renal Replacement Therapy Market, by Age Group
9 Global Continuous Renal Replacement Therapy Market, by Region
10 Competitive Landscape
11 Company Profiles
11.1 Major Players
11.1.1 Baxter International Inc.
18.104.22.168 Business Overview
22.214.171.124 Products Offered
126.96.36.199 Recent Developments
188.8.131.52 Analyst's View
11.1.2 Fresenius Medical Care AG & Co. KGaA
184.108.40.206 Business Overview
220.127.116.11 Products Offered
18.104.22.168 Recent Developments
22.214.171.124 Analyst's View
11.1.3 NIKKISO Co. Ltd.
126.96.36.199 Business Overview
188.8.131.52 Products Offered
184.108.40.206 Analyst's View
11.1.4 B. Braun Melsungen AG
220.127.116.11 Business Overview
18.104.22.168 Products Offered
22.214.171.124 Recent Developments
126.96.36.199 Analyst's View
11.1.5 Medtronic plc
188.8.131.52 Business Overview
184.108.40.206 Products Offered
220.127.116.11 Recent Developments
11.1.6 Asahi Kasei Corporation
18.104.22.168 Business Overview
22.214.171.124 Products Offered
11.1.7 Toray Medical Co. Ltd.
126.96.36.199 Business Overview
188.8.131.52 Products Offered
11.1.8 Nipro Corporation
184.108.40.206 Business Overview
220.127.116.11 Products Offered
18.104.22.168 Recent Developments
11.1.9 Infomed SA
22.214.171.124 Business Overview
126.96.36.199 Products Offered
188.8.131.52 Recent Developments
184.108.40.206 Analyst's View
11.1.10 Medica S.p.A.
220.127.116.11 Business Overview
18.104.22.168 Products Offered
11.1.11 Medites Pharma Spol. S.R.O
22.214.171.124 Business Overview
126.96.36.199 Products Offered
11.1.12 Medical Components, Inc.
188.8.131.52 Business Overview
184.108.40.206 Products Offered
11.1.13 SWS Hemodialysis Care Co. Ltd.
220.127.116.11 Business Overview
18.104.22.168 Products Offered
22.214.171.124 Recent Developments
11.1.14 Ningbo Tianyi Medical Devices Co. Ltd.
126.96.36.199 Business Overview
188.8.131.52 Products Offered
11.1.15 Anjue Medical Equipment Co. Ltd.
184.108.40.206 Business Overview
220.127.116.11 Products Offered
11.2 Emerging Players
11.2.2 Jiangxi Sanxin Medtec Co. Ltd.
11.2.3 Allmed Medical Products Co. Ltd.
11.2.4 Dialco Medical Inc.
11.2.5 Browndove Healthcare Pvt. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/7jdub4
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900